S100A9 as a Theranostic Marker for Rheumatoid Arthritis Treatment

Imagine being able to pre-determine success when choosing a drug combination for a patient. Selecting those individuals most likely to respond well to a complicated or expensive treatment regime could minimize unnecessary side effects and provide truly personalized medicine. This already occurs every day when clinicians use their expert diagnostic judgment, but now researchers have launched an investigation into the realm of serum Read the rest of this article

The post S100A9 as a Theranostic Marker for Rheumatoid Arthritis Treatment appeared first on Accelerating Science.

from http://ift.tt/1zQNrMX
via IFTTT

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s